Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization
- 1 July 2011
- journal article
- research article
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 55 (4), 378-382
- https://doi.org/10.1007/s10384-011-0034-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab—A Randomized Controlled TrialAmerican Journal of Ophthalmology, 2010
- Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot studyBritish Journal of Ophthalmology, 2008
- Intravitreal Bevacizumab for Choroidal Neovascularization Attributable to Pathological Myopia: One-Year ResultsAmerican Journal of Ophthalmology, 2008
- Progression from macular retinoschisis to retinal detachment in highly myopic eyes is associated with outer lamellar hole formationBritish Journal of Ophthalmology, 2008
- Intravitreal Bevacizumab (Avastin) for Myopic Choroidal NeovascularizationOphthalmology, 2007
- Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopiaBritish Journal of Ophthalmology, 2007
- Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopiaBritish Journal of Ophthalmology, 2007
- Ultrastructure of internal limiting membrane in myopic foveoschisisAmerican Journal of Ophthalmology, 2004
- Macular Complications Associated With Posterior StaphylomaAmerican Journal of Ophthalmology, 1997
- Axial Length Measurements and Fundus Changes of the Myopic EyeAmerican Journal of Ophthalmology, 1971